| COMMON NAME |
2857916, GSK2857916, J6M0, J6M0-mcMMAF |
|---|---|
| SYNONYMS |
CD269;TNFRSF17;BCM;BCMA |
| APPLICATIONS |
ELISA |
| RECOMMENDED DILUTIONS |
ELISA 1:5000-10000 |
| FORMULATION & RECONSTITUTION |
Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| HOST SPECIES |
Humanized |
| IGG TYPE |
IgG1 |
| REACTIVITY |
Human |
| TARGET | |
| UNIPROT ID |
Q02223 |
| DESCRIPTION |
Anti-BCMA ( belantamab biosimilar) mAb |
| DELIVERY |
In Stock |
| STORAGE & SHIPPING |
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
| BACKGROUND |
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| USAGE |
Research use only |
Dima Biotech
SKU(재고 관리 코드):BME100028
Anti-BCMA ( belantamab biosimilar) mAb
Anti-BCMA ( belantamab biosimilar) mAb
PRODUCT DATA
IMAGES
Figure 1. ELISA plate pre-coated by 2 μg/ml (100 μl/well) Human BCMA, mFc tagged protein (PME100035) can bind Anti-BCMA Neutralizing antibody in a linear range of 0.64-80.0 ng/ml
